Why Weight Watchers is buying a company that prescribes popular weight-loss drugs like Ozempic

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 97%

United States News News

United States United States Latest News,United States United States Headlines

It's the latest example how a new class of therapies has revolutionized the way many Americans think about weight loss.

Weight Watchers is buying a telehealth provider that prescribes sought-after weight-management and diabetes drugs in a deal that reinforces how a new class of therapies has revolutionized the way many Americans think about weight loss.

WW International Inc. WW announced Monday night that it’s spending $132 million to buy Weekend Health Inc., a privately held company that operates a telehealth platform called Sequence that is focused on weight management. Despite profoundly lackluster results in the fourth quarter, and stalled subscriber growth, WW’s shares soared on the news that the company is entering the GLP-1 market. The stock was up about 40% in trading on Tuesday.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

I’m diabetic, I went to the pharmacy to pick up my prescription for Ozempic, I was told there was a shortage, they didn’t know when it was coming, so while waiting my blood sugar went yo 800, & I was hospitalized for 4 days trying to get my blood sugar under control. Shame on you

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in US

United States United States Latest News, United States United States Headlines